The use of flufenamic acid in acute complications of leprosy, and the associated lowering of raised serum transaminase levels.
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001219:Aspartate Aminotransferases / Q000097:blood; D001799:Blood Sedimentation; D002648:Child; D004893:Erythema Nodosum / Q000188:drug therapy; D005260:Female; D005334:Fever / Q000188:drug therapy; D005439:Flufenamic Acid / Q000009:adverse effects / Q000627:therapeutic use; D005461:Fluorine / Q000627:therapeutic use*; D006801:Humans; D007918:Leprosy / Q000150:complications* / Q000201:enzymology; D008297:Male; D008875:Middle Aged; D009443:Neuritis / Q000188:drug therapy; D014606:Uveitis, Anterior / Q000188:drug therapy; D062367:ortho-Aminobenzoates / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D062367:ortho-Aminobenzoates; D005461:Fluorine; D005439:Flufenamic Acid; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase